Miscioscia, Alessandro http://orcid.org/0000-0001-7465-6246
Puthenparampil, Marco
Miante, Silvia
Pengo, Marta
Rinaldi, Francesca
Perini, Paola
Gallo, Paolo
Funding for this research was provided by:
Università degli Studi di Padova
Article History
Received: 21 March 2022
Revised: 7 May 2022
Accepted: 11 May 2022
First Online: 1 June 2022
Declarations
:
: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: A.M., S.M., M.Pe. have no conflicts to disclose. M.Pu., F.R. report grants from Almirall, Teva, Sanofi Genzyme, Merck Serono, Biogen Italy, Novartis; consultancy for Novartis, Biogen Italy, Sanofi Genzyme. P.P. reports grants from Almirall, Teva, Sanofi Genzyme, Merck Serono, Biogen Italy, Novartis, Roche; consultancy for Novartis, Biogen Italy, Sanofi Genzyme, Roche. P.G. reports grants from Almirall, Teva, Sanofi Genzyme, Merck Serono, Biogen Italy, Novartis, Roche, Bristol Myers Squibb; consultancy for Novartis, Biogen Italy, Sanofi Genzyme, Roche, Bristol Myers Squibb; board membership Sanofi Genzyme, Novartis, Biogen Italy, Roche, Merck Serono, Bristol Myers Squibb.
: The study was approved by the Ethics Committee of University Hospital (Comitato Etico per la Sperimentazione, Azienda Ospedaliera Universitaria di Padova – 52511) and carried out in accordance with the Declaration of Helsinki.
: Written informed consent was obtained by all the participants.